These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
430 related articles for article (PubMed ID: 7533050)
1. Novel neuroleptics in schizophrenia: theory and clinical relevance. Remington GJ Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S43-5. PubMed ID: 7533050 [No Abstract] [Full Text] [Related]
2. Pharmacotherapy of schizophrenia: a review. Sigmundson HK Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S70-5. PubMed ID: 7533053 [TBL] [Abstract][Full Text] [Related]
3. Antipsychotic medication in the treatment of schizophrenia. Kane JM Isr J Psychiatry Relat Sci; 1995; 32(1):30-7. PubMed ID: 7542642 [TBL] [Abstract][Full Text] [Related]
4. New drug offers hope for people with schizophrenia. J Psychosoc Nurs Ment Health Serv; 1994 May; 32(5):46. PubMed ID: 7519676 [No Abstract] [Full Text] [Related]
5. New antipsychotic medications: do research results relate to clinical practice? MacEwan GW Can J Psychiatry; 1993 Sep; 38 Suppl 3():S75-9. PubMed ID: 7504572 [TBL] [Abstract][Full Text] [Related]
6. Schizophrenia and severe tardive dyskinesia responsive to risperidone. Kopala LC; Honer WG J Clin Psychopharmacol; 1994 Dec; 14(6):430-1. PubMed ID: 7533794 [No Abstract] [Full Text] [Related]
7. Pathophysiology and treatment of negative symptoms. Villeneuve A Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S53-8. PubMed ID: 7533052 [TBL] [Abstract][Full Text] [Related]
8. Clinical review of risperidone. Chouinard G; Arnott W Can J Psychiatry; 1993 Sep; 38 Suppl 3():S89-95. PubMed ID: 7504574 [TBL] [Abstract][Full Text] [Related]
9. Ethical issues in drug selection for schizophrenia. Jeffries JJ Can J Psychiatry; 1993 Sep; 38 Suppl 3():S70-4. PubMed ID: 7504571 [TBL] [Abstract][Full Text] [Related]
10. Risperidone: neurochemical, pharmacologic and clinical properties of a new antipsychotic drug. Keegan D Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S46-52. PubMed ID: 7533051 [TBL] [Abstract][Full Text] [Related]
11. Clinical considerations in the use of risperidone. Remington GJ Can J Psychiatry; 1993 Sep; 38 Suppl 3():S96-100. PubMed ID: 7504575 [TBL] [Abstract][Full Text] [Related]
12. Schizophrenia, violence, clozapine and risperidone: a review. The Special Hospitals Treatment Resistant Schizophrenia Research Group. Br J Psychiatry Suppl; 1996 Dec; (31):21-30. PubMed ID: 8968652 [No Abstract] [Full Text] [Related]
13. Dystonic reaction and relapse with clozapine discontinuation and risperidone intiation. Dickson R; Williams R; Dalby JT Can J Psychiatry; 1994 Apr; 39(3):184. PubMed ID: 7518338 [No Abstract] [Full Text] [Related]
15. [New psychopharmacologic alternatives in treatment of schizophrenia]. Bryois C Schweiz Arch Neurol Psychiatr (1985); 1994; 145(6):19-24. PubMed ID: 7533941 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of a new antipsychotic compound (risperidone): results of a pilot study. Möller HJ; Pelzer E; Kissling W; Riehl T; Wernicke T Pharmacopsychiatry; 1991 Nov; 24(6):185-9. PubMed ID: 1725925 [TBL] [Abstract][Full Text] [Related]